﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>BioImpacts</JournalTitle>
      <Issn>2228-5652</Issn>
      <Volume>12</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2022</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Intra-ovarian injection of bone marrow-derived c-Kit+ cells for ovarian rejuvenation in menopausal rats</ArticleTitle>
    <FirstPage>325</FirstPage>
    <LastPage>335</LastPage>
    <ELocationID EIdType="doi">10.34172/bi.2021.23499</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Sheshpari</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-8590-8111</Identifier>
      </Author>
      <Author>
        <FirstName>Mahnaz</FirstName>
        <LastName>Shahnazi</LastName>
      </Author>
      <Author>
        <FirstName>Shahin</FirstName>
        <LastName>Ahmadian</LastName>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Nouri</LastName>
      </Author>
      <Author>
        <FirstName>Mehran</FirstName>
        <LastName>Mesgari Abbasi</LastName>
      </Author>
      <Author>
        <FirstName>Rahim</FirstName>
        <LastName>Beheshti</LastName>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Rahbarghazi</LastName>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Honaramooz</LastName>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Mahdipour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2729-4593</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/bi.2021.23499</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2020</Year>
        <Month>11</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>04</Month>
        <Day>22</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Cell-based therapies with certain cell types are touted as novel and hopeful therapeutic intervention in the clinical setting. Here, we aimed to assess the regenerative potential of c-Kit+ cells in the rejuvenation of ovarian tissue and fertility rate in rat model of premature ovarian failure (POF).  Methods: Rats were treated with 160 mg/kg/BW of 4-vinylcyclohexene dioxide for 15 days. Freshly enriched rat bone marrow-derived c-Kit+ (MACS) and c-Kit- cells (4×105 cells/10 µL) were transplanted into the ovaries of treatment and control animals. Prior to transplantation as well as 2, 4, 6, and 8 weeks post-transplantation, randomly-selected rats were euthanized and ovarian tissues were subjected to pathophysiological examinations and real-time PCR analyses.  Results: POF status was confirmed by the presence of pathological features and a decreased number of immature and mature follicles compared with the control group (P &lt; 0.05). Histological examination revealed a substantial reduction of atretic follicles in POF rats receiving c-Kit+ cells in comparison with POF rats that did not receive these cells (P &lt; 0.05). Compared with the control samples, angiogenesis-related genes, Angpt2 and KDR, showed increased and decreased expressions in POF ovaries, respectively (P &lt; 0.05). c-Kit+ cells had potential to restore angiogenesis in the ovarian tissue within normal ranges. Systemic levels of FSH did not significantly change in pre- or post-transplantation time points for any group (P &gt; 0.05). Notable reduction of collagen deposition was found in c-Kit-treated rats. Transplantation of c-Kit+ cells also restored the reduced fertility rate (P &lt; 0.05).  Conclusion: The administration of c-Kit+ cells can modulate angiogenesis and pathological changes, leading to the rejuvenation of ovarian function of a rat model of premature menopause.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Premature ovarian failure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Bone marrow c-Kit+ cells</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Follicular competence</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Angiogenesis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Fertility</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>